Patents by Inventor Min-hyuk BANG

Min-hyuk BANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compound promoting osteoblast differentiation and inhibiting adipocyte differentiation, preparation method thereof and application thereof
    Patent number: 10494356
    Abstract: The present disclosure relates to a compound having the activity of promoting osteoblast differentiation and inhibiting adipocyte differentiation and a preparation method thereof. The novel compound of the present disclosure increases the expression of the gene ALP involved in the differentiation of osteoblasts, regulates expression of the genes PPAR?, aP2 and CD36 involved in the differentiation of adipocytes, increases bone mineral density (BMD) in an ovariectomized osteoporosis animal model and decreases adipocytes in the bone marrow. Therefore, it can be used as an active ingredient of a medication or a health functional food useful for metabolic bone disease or obesity.
    Type: Grant
    Filed: May 12, 2017
    Date of Patent: December 3, 2019
    Assignee: SUNG KYUN BIOTECH CO., LTD.
    Inventors: Hyun Suk Kim, Kimoon Park, Min-hyuk Bang, Hee-Jin Yang, Yun Mi Lee, Ki Hyun Kim
  • NOVEL COMPOUND PROMOTING OSTEOBLAST DIFFERENTIATION AND INHIBITING ADIPOCYTE DIFFERENTIATION, PREPARATION METHOD THEREOF AND APPLICATION THEREOF
    Publication number: 20190152935
    Abstract: The present disclosure relates to a compound having the activity of promoting osteoblast differentiation and inhibiting adipocyte differentiation and a preparation method thereof. The novel compound of the present disclosure increases the expression of the gene ALP involved in the differentiation of osteoblasts, regulates expression of the genes PPAR?, aP2 and CD36 involved in the differentiation of adipocytes, increases bone mineral density (BMD) in an ovariectomized osteoporosis animal model and decreases adipocytes in the bone marrow. Therefore, it can be used as an active ingredient of a medication or a health functional food useful for metabolic bone disease or obesity.
    Type: Application
    Filed: May 12, 2017
    Publication date: May 23, 2019
    Applicant: SUNG KYUN BIOTECH CO., LTD.
    Inventors: Hyun Suk KIM, Kimoon PARK, Min-hyuk BANG, Hee-Jin YANG, Yunmi LEE, Ki Hyun KIM